1 / 9

Hematology/Oncology Fellowship

Hematology/Oncology Fellowship. Kristie A. Blum, M.D. Gregory Otterson, M.D. The Ohio State University Department of Medicine, Division of Hematology & Oncology and The Comprehensive Cancer Center. ABIM Fellowship Requirements. Hematology Board eligible – 2 year program

merry
Download Presentation

Hematology/Oncology Fellowship

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Hematology/Oncology Fellowship Kristie A. Blum, M.D. Gregory Otterson, M.D. The Ohio State University Department of Medicine, Division of Hematology & Oncology and The Comprehensive Cancer Center

  2. ABIM Fellowship Requirements • Hematology Board eligible – 2 year program • 12 months clinical service time • 12 months research • Laboratory or Clinical • ½ day continuity clinic • Oncology Board eligible – 2 year fellowship • 12 months service time • 12 months research • Laboratory or Clinical • ½ day continuity clinic • Hematology/Oncology Board eligible (DUAL CERTIFICATION) – 2 year fellowship • 18 months service time • 18 months research • Laboratory or Clinical • ½ day continuity clinic

  3. Research Opportunities • Clinical Research • Specific training in the design/writing of clinical trials • Learn how to consent and enroll patients on trial, record toxicities, and analyze the data • Learn how to present and publish results/learn grant writing • Laboratory Research • Bench research: available in many areas (vascular biology/angiogenesis of tumors, genetic changes, cellular signaling changes, methods of tumor invasion, activity of new drugs, apoptosis/cell death, stem cell biology) • Learn how to present and publish results/learn grant writing • Can combine both clinical and laboratory research – many clinical trials have a laboratory/translational component • MENTOR, MENTOR, MENTOR…….

  4. Heme/Onc board eligible – 3 year program 18 months service time 3 months He2 2 months He1 2 months BMT 3 months Onc2 3 months Consults 1 month Hospice&PC 1 month Heme path 0.5 month Blood bank 2.5 months elective 18 months research Med Onc board eligible – 2 year fellowship 12 months service time 2 months He2 1 months He1 1 months BMT 3 months Onc2 2 months Consults 1 month Hospice&PC 1 month Heme path 1 month elective 12 months research Fellowship requirements

  5. Heme/Onc board certified – 18 months ½ day continuity for all 18 months ½ day ambulatory clinic 6 months benign heme 3 months malignant heme 3 months solid tumor 3 months solid tumor 3 months solid tumor Med Onc certified – 12 months ½ day continuity for all 12 months ½ day ambulatory clinic 3 months malignant heme 3 months malignant heme 3 months solid tumor 3 months solid tumor Clinic schedule

  6. Heme/Onc – 18 months Clinical investigator pathway 2 – ½ day clinics per week ½ day continuity ½ day fellow’s choice Complete CI training (includes writing protocol, LOI, grants, retrospective papers) Laboratory investigator pathway ½ day continuity clinic Laboratory training Med Onc – 12 months Clinical investigator pathway 2 – ½ day clinics per week ½ day continuity ½ day fellow’s choice Complete CI training (includes writing protocol, LOI, grants, retrospective papers) Laboratory investigator pathway ½ day continuity clinic Laboratory training Protected time

  7. Practice Opportunities • Academics • Mostly disease focused • For example: Lung, GI, GU, Breast, Head and Neck, Endocrine, lymphoma, leukemia, myeloma focused • Some portion of protected time to conduct laboratory or clinical research or both • Somewhat less lucrative than private practice • Benefits • disease focus • opportunity to do research • Interact with housestaff, fellows – can participate in education • Share call with faculty, fellows, nurse practitioners

  8. Practice Opportunities • Private practice • Usually all malignancies • Some practices do permit practitioners with some disease focus • Do usually have a few practitioners who see benign hematology, although not all members of the practice may be hematology certified • Fairly Lucrative • Busy call and clinic schedule – frequent consults, cover own inpatients and consults, clinic 3-5 days/week • Benefits • Busy practice, opportunity to see many different malignancies • Limited or no research, although many cancer centers participate in national pharmaceutical or co-operative group trials • Some educational opportunities

  9. Professional Organizations • American Society of Hematology • Focuses on benign and malignant hematology • Clinical and bench research • American Society of Clinical Oncology • Focuses primarily on solid tumors, although some representation of malignant hematology • Clinical and bench research • Co-operative Groups • CALGB, ECOG, SWOG – groups that conduct clinical trials at multiple sites

More Related